Consensus Qiagen N.V.

Equities

QGEN

NL0015001WM6

Market Closed - Nyse Other stock markets 04:00:02 2024-04-25 pm EDT			5-day change	1st Jan Change
41.08 ^USD	-1.06%		+4.08%	-8.25%

Apr. 22	European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations	MT
Apr. 16	QIAGEN NV : Deutsche Bank reiterates its Buy rating	ZD

Evolution of the average Target Price on Qiagen N.V.

Price target over the last 5 years

History of analyst recommendation changes

4e9c623e69c2dca310dcda68acbc.e9FGUt9COsxp501yE56XcQStiIZruotQBALj6_iTItk.PZQ_JegQbKEtvQsTdeTnQzbZwPYm8MEqUzOGnZD9apAqnXVr5iB8jwWEHA~29207c427080d4daef30c2e7357952d1

Analyst Recommendations on Qiagen N.V.

QIAGEN NV : Deutsche Bank reiterates its Buy rating	Apr. 16	ZD
QIAGEN NV : UBS reaffirms its Neutral rating	Mar. 01	ZD
Morgan Stanley Upgrades Qiagen to Overweight From Equalweight, Adjusts Price Target to $49.48 From $51	Feb. 16	MT
QIAGEN NV : Berenberg reiterates its Buy rating	Feb. 16	ZD
QIAGEN NV : Deutsche Bank remains its Buy rating	Feb. 14	ZD
QIAGEN NV : JP Morgan reiterates its Buy rating	Feb. 08	ZD
QIAGEN NV : UBS reiterates its Neutral rating	Feb. 08	ZD
QIAGEN : In line Q4; routine business prospects remain intact	Feb. 07
QIAGEN NV : Gets a Neutral rating from UBS	Feb. 07	ZD
QIAGEN NV : Berenberg reaffirms its Buy rating	Feb. 07	ZD
QIAGEN NV : DZ Bank gives a Buy rating	Feb. 07	ZD
QIAGEN NV : Deutsche Bank reiterates its Buy rating	Feb. 07	ZD
BofA Securities Raises Price Target on Qiagen to $55 From $52, Maintains Buy Rating	Jan. 29	MT
QIAGEN NV : Buy rating from Deutsche Bank	Jan. 26	ZD
QIAGEN NV : Berenberg reiterates its Buy rating	Jan. 18	ZD
QIAGEN NV : Morgan Stanley keeps its Buy rating	Jan. 08	ZD
QIAGEN NV : UBS reiterates its Neutral rating	Jan. 05	ZD
QIAGEN NV : UBS sticks Neutral	Jan. 03	ZD
UBS Ups Price Target on Qiagen to $44 From $42, Keeps Neutral Rating	Jan. 02	MT
QIAGEN NV : Gets a Buy rating from JP Morgan	Dec. 19	ZD
Wells Fargo Initiates Qiagen at Equal-Weight Rating With $44 Price Target	Dec. 19	MT
BofA Securities Adjusts Price Target on Qiagen to $52 From $44, Maintains Buy Rating	Dec. 12	MT
QIAGEN : Incorporating some weakness	Dec. 11
Goldman Sachs Upgrades Qiagen to Buy From Neutral, Raises Price Target to $50 From $47	Dec. 07	MT
QIAGEN NV : Berenberg reiterates its Buy rating	Dec. 07	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

41.08 USD

Average target price

50.75 USD

Spread / Average Target

+23.55%

High Price Target

61.86 USD

Spread / Highest target

+50.57%

Low Price Target

42.5 USD

Spread / Lowest Target

+3.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Qiagen N.V.

DEUTSCHE BANK RESEARCH	Falko Friedrichs
UBS	John Sourbeer
Morgan Stanley
BERENBERG	Odysseas Manesiotis
alphavalue	Anas Patel
DZ BANK	Sven Kürten
JPMORGAN	Casey Woodring
BofA Securities
Wells Fargo Securities
Goldman Sachs
JEFFERIES	Peter Welford
JPMorgan Chase
Baird
Invest Securities
Citigroup
DEUTSCHE BANK	Falko Friedrichs
KEPLER CHEUVREUX	Oliver Reinberg
Redburn
NORDLB	Thorsten Strauß
WARBURG RESEARCH	Ulrich Huwald
INDEPENDENT RESEARCH	Tobias Gottschalt
BARCLAYS	Jack Meehan
COMMERZBANK	Daniel Wendorff
EVERCORE ISI

Ratings for Qiagen N.V.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar